Yong Lu PhD

Dr. Yong Lu joined Houston Methodist Academic Institute in November 2021. He is an awardee of the 2021 Cancer Prevention & Research Institute of Texas Rising Stars program which recruits early-stage investigators who have demonstrated the promise for continued and enhanced contributions to the field of cancer research.
,/br> Before joining Houston Methodist, he was a co-leader of the Wake Forest Baptist Comprehensive Cancer Center for Signaling and Biotechnology (SBT) program. During 2019-2021, he was a member of NCI’s cell-based immunotherapy network to (A) provide NCI with advice on the research gaps in cancer adoptive cell therapy; and (B) advise the NCI on future directions of cancer adoptive cell therapy. Dr. Lu’s work focuses on translational T cell-based adoptive cell immunotherapy, targeting lung cancer, pancreatic cancer, and other cancers.